Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... of the Novartis Foundation (GNF), as she presents on "High Content HTS Support for Drug Discovery Efforts", Friday 20th November at 11am. As part of her presentation, Dr Gardiner will ...
2009 NOV 26 ... and inflammatory targets, announced that in conjunction with a transformation to a drug discovery collaboration business model, it has created a new division, Ansaris, which will include ...
2009 NOV 24 ... analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the ...
2009 NOV 23 ... The researchers concluded: "Our experimental approach suggests that rational drug design can develop new rexinoids with improved biological properties." ... as for their mutagenicity and cytotoxicity. Analysis of 11 novel compounds revealed the discovery of three analogues that best induce RXR-mediated transcriptional activity, stimulate ...
2009 NOV 23 ... interaction studies with lipid model membranes could play an important role in drug discovery and drug delivery." Peetla and colleagues published their study in ...
2009 NOV 27 ... Biology Program, which is directed by Stuart Schreiber.Verdine invented a drug discovery technology that uses chemical braces or "staples" to hold the shapes of different ...
2009 NOV 23 ... great promise for the development of in vitro models of cardiac genetic disorders, for drug discovery and testing, and for the emerging field of cardiovascular regenerative medicine. ...
2009 NOV 23 ... the November 2007 agreement governing the development and commercialization of antibody drug candidates arising from the discovery collaboration. "The first two years ...
2009 NOV 26 ... men really want to know about, including how to survive an elephant attack, whether drug sniffing dogs can get high and what the record number is for having sex in one day. Each ... since the company's inception. In 2009, a record 101 hours of new shows just for Discovery and History alone are currently in production. In February 2009, a majority stake in the ...
2009 NOV 23 ... in the areas of infectious and neglected diseases. CADRE extends SRI's expertise in drug discovery and development and biomedical sciences with a new proteomics laboratory to develop ...
2009 NOV 23 ... onset motor neuron degeneration. Despite intensive research, riluzole remains the only drug with proven efficacy," scientists writing in the journal Current Opinion in Neurology ... forms of ALS and improvements in the treatment of ALS patients. Recent findings The discovery of mutations in the DNA/RNA-binding proteins transactive response DNA-binding protein 43 ...
2009 NOV 23 ... operations." Ray and colleagues published their study in Nature Reviews Drug Discovery (Beyond debacle and debate: developing solutions in drug safety. Nature Reviews...
2009 NOV 27 ... represent an underexplored reservoir of novel actinomycetes of potential interest for drug discovery."Peraud and colleagues published their study in Applied and Environmental ...
2009 NOV 23 ... (MD) simulations and docking calculations was employed to model and predict polymer-drug interactions in self-assembled nanoparticles consisting of ABA-type triblock copolymers, ... pairs hold the potential of becoming a powerful prescreening tool in the process of discovery, development and optimization of new drug delivery systems, reducing both the time and ...
2009 NOV 23 ... per dose level; each subject received up to 3 single escalating doses of study drug. Dosing followed an overnight fast of at least 8 hours. In the MAD study, 5 dose groups ... Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, announced ...
2009 NOV 23 ... of blood pressure and has been a broadly pursued but extremely difficult target to drug within the pharmaceutical industry for many years. Within the bloodstream, renin ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced the company's novel, clinical-stage renin inhibitor, ...
2009 NOV 23 ... has broad economic implications for researchers discovering biomarkers and across the drug development industry, particularly for companies seeking ways to reduce time to market ... PCR System. The SmartChip Real-Time PCR System is designed to boost pathway-based gene discovery and exploration enabling researchers to discover new gene markers that could be missed ...
2009 NOV 29 ... findings provide insight into the evolution of the human brain and may point to possible drug targets for human disorders characterized by speech disruption, such as autism and ... studying how human speech could be regulated at the molecular level."The discovery will provide insight into the evolution of humans' ability to learn through the use of ...
